Tumor biology is complex. Most models oversimplify biology and lose important context. elive™ is a first‑in‑class functional assay that preserves biology and makes it measurable. By capturing dynamic cytokine activity ex vivo, elive overcomes the limitations of static testing and provides a more accurate prediction of therapeutic responsiveness.

elive reveals immune activity in response to therapies enabling a stronger correlation with and translation to a clinical setting.

• Basic researchers benefit from mechanistic immune-tumor insight in preserved human architecture.

• Translational teams benefit from functional response data anchored in human biology.

• Early drug developers get earlier, more confident go/no-go decisions.